Moreover, GPX4 has been identified as a critical survival protein for cancer cells in a high mesenchymal therapy‐resistant cell state in the antilipid peroxidase pathway 14, 23 while there is a paucity of studies investigating the effects of NR2F2 on drug resistance. The gene discussed is GPX4; the disease is cancer.